Cubist Systematic Strategies’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
+193,857
| New | +$1.26M | 0.01% | 844 |
|
|
2024
Q4 | – | Sell |
-68,064
| Closed | -$948K | – | 1664 |
|
|
2024
Q3 | $948K | Buy |
+68,064
| New | +$948K | 0.01% | 829 |
|
|
2024
Q1 | – | Sell |
-14,395
| Closed | -$210K | – | 2359 |
|
|
2023
Q4 | $210K | Buy |
+14,395
| New | +$210K | ﹤0.01% | 1636 |
|
|
2023
Q2 | – | Sell |
-172,408
| Closed | -$2.31M | – | 2430 |
|
|
2023
Q1 | $2.31M | Buy |
172,408
+128,850
| +296% | +$1.72M | 0.01% | 1045 |
|
|
2022
Q4 | $937K | Sell |
43,558
-82,028
| -65% | -$1.77M | 0.01% | 1801 |
|
|
2022
Q3 | $2.52M | Buy |
125,586
+64,349
| +105% | +$1.29M | 0.01% | 1395 |
|
|
2022
Q2 | $1.1M | Buy |
+61,237
| New | +$1.1M | 0.01% | 2060 |
|